Literature DB >> 15259013

Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics.

Joseph R Tumang1, William D Hastings, Chunyan Bai, Thomas L Rothstein.   

Abstract

B-1 cells constitute a distinct B cell population with unique phenotypic and functional characteristics. Although the origin of B-1 cells remains controversial, B-1 cells in different locations are generally considered to be part of the same pool. To determine the validity of this assumption, we examined peritoneal and splenic B-1 cells isolated by flow cytometric cell sorting from normal mice for several features. We found that splenic B-1 cells differ from peritoneal B-1 cells in terms of surface antigen expression, viability ex vivo, immunoglobulin secretion in vitro, stimulated cell cycle progression, and expression of Notch family, Notch-dependent, and Notch-associated genes. These results indicate that splenic and peritoneal B-1 cells are not the same and thus dispute the notion that B-1 cells are uniform, and may suggest that different subpopulations of B-1 cells arise separately, home individually, and/or are heavily influenced by local environmental factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259013     DOI: 10.1002/eji.200424819

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

Review 1.  L2pB1: a new player in autoimmunity.

Authors:  Xuemei Zhong; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2010-12-31       Impact factor: 4.407

2.  Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3.

Authors:  Dennis C Otero; Valeria Poli; Michael David; Robert C Rickert
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry.

Authors:  Kristina Rothaeusler; Nicole Baumgarth
Journal:  Cytometry A       Date:  2006-04       Impact factor: 4.355

4.  CD19+CD5+ B cells in primary IgA nephropathy.

Authors:  He Yuling; Xiao Ruijing; Ji Xiang; Jiang Yanping; Chen Lang; Li Li; Yang Dingping; Tan Xinti; Liu Jingyi; Tang Zhiqing; Bi Yongyi; Xia Bing; Wu Xinxing; Jin Youxin; David A Fox; Steven K Lundy; Ding Guohua; Tan Jinquan
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

Review 5.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

6.  BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.

Authors:  Jean L Scholz; Jenni E Crowley; Mary M Tomayko; Natalie Steinel; Patrick J O'Neill; William J Quinn; Radhika Goenka; Juli P Miller; Yun Hee Cho; Vatana Long; Chris Ward; Thi-Sau Migone; Mark J Shlomchik; Michael P Cancro
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

Review 7.  Cellular and chromatin dynamics of antibody-secreting plasma cells.

Authors:  Alexandra Bortnick; Cornelis Murre
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-10-21       Impact factor: 5.814

8.  Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration.

Authors:  Julie C Williams; Nikki J Wagner; H Shelton Earp; Barbara J Vilen; Glenn K Matsushima
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

9.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

10.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.